{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:09:18Z","timestamp":1790359758141,"version":"4.1.0"},"reference-count":45,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T00:00:00Z","timestamp":1531180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Feline immunodeficiency virus (FIV) is a member of the retroviridae family of viruses. It causes acquired immunodeficiency syndrome (AIDS) in worldwide domestic and non-domestic cats and is a cause of an important veterinary issue. The genome organization of FIV and the clinical characteristics of the disease caused by FIV are similar to human immunodeficiency virus (HIV). Both viruses infect T lymphocytes, monocytes, and macrophages, with a similar replication cycle in infected cells. Thus, the infection of cats with FIV is also a useful tool for the study and development of novel drugs and vaccines against HIV. Anti-retroviral drugs studied extensively with regards to HIV infection have targeted different steps of the virus replication cycle: (1) disruption of the interaction with host cell surface receptors and co-receptors; (2) inhibition of fusion of the virus and cell membranes; (3) blocking of the reverse transcription of viral genomic RNA; (4) interruption of nuclear translocation and integration of viral DNA into host genomes; (5) prevention of viral transcript processing and nuclear export; and (6) inhibition of virion assembly and maturation. Despite the great success of anti-retroviral therapy in slowing HIV progression in humans, a similar therapy has not been thoroughly investigated for FIV infection in cats, mostly because of the little structural information available for FIV proteins. The FIV capsid protein (CA) drives the assembly of the viral particle, which is a critical step in the viral replication cycle. During this step, the CA protein oligomerizes to form a protective coat that surrounds the viral genome. In this work, we perform a large-scale screening of four hundred molecules from our in-house library using an in vitro assembly assay of p24, combined with microscale thermophoresis, to estimate binding affinity. This screening led to the discovery of around four novel hits that inhibited capsid assembly in vitro. These may provide new antiviral drugs against FIV.<\/jats:p>","DOI":"10.3390\/ph11030067","type":"journal-article","created":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T10:01:46Z","timestamp":1531216906000},"page":"67","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Looking for Novel Capsid Protein Multimerization Inhibitors of Feline Immunodeficiency Virus"],"prefix":"10.3390","volume":"11","author":[{"given":"Natalia","family":"Sierra","sequence":"first","affiliation":[{"name":"Laboratorio de Mol\u00e9culas Bioactivas, CENUR Litoral Norte, Universidad de la Rep\u00fablica, Ruta 3 (km 363), Paysand\u00fa C.P. 60000, Uruguay"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Folio","sequence":"additional","affiliation":[{"name":"Equipe R\u00e9trovirus et Biochimie Structurale, Universit\u00e9 de Lyon, CNRS, MMSB, UMR 5086 CNRS\/Universit\u00e9 de Lyon, IBCP, C.P. 69367 Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6174-8595","authenticated-orcid":false,"given":"Xavier","family":"Robert","sequence":"additional","affiliation":[{"name":"Equipe R\u00e9trovirus et Biochimie Structurale, Universit\u00e9 de Lyon, CNRS, MMSB, UMR 5086 CNRS\/Universit\u00e9 de Lyon, IBCP, C.P. 69367 Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Long","sequence":"additional","affiliation":[{"name":"Equipe R\u00e9trovirus et Biochimie Structurale, Universit\u00e9 de Lyon, CNRS, MMSB, UMR 5086 CNRS\/Universit\u00e9 de Lyon, IBCP, C.P. 69367 Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6378-3303","authenticated-orcid":false,"given":"Christophe","family":"Guillon","sequence":"additional","affiliation":[{"name":"Equipe R\u00e9trovirus et Biochimie Structurale, Universit\u00e9 de Lyon, CNRS, MMSB, UMR 5086 CNRS\/Universit\u00e9 de Lyon, IBCP, C.P. 69367 Lyon, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8385-6100","authenticated-orcid":false,"given":"Guzm\u00e1n","family":"\u00c1lvarez","sequence":"additional","affiliation":[{"name":"Laboratorio de Mol\u00e9culas Bioactivas, CENUR Litoral Norte, Universidad de la Rep\u00fablica, Ruta 3 (km 363), Paysand\u00fa C.P. 60000, Uruguay"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2018,7,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2460\/ajvr.75.3.273","article-title":"Antiviral efficacy of nine nucleoside reverse transcriptase inhibitors against feline immunodeficiency virus in feline peripheral blood mononuclear cells","volume":"75","author":"Schwartz","year":"2014","journal-title":"Am. J. Vet. Res."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"708","DOI":"10.3390\/v4050708","article-title":"Pharmacological inhibition of feline immunodeficiency virus (FIV)","volume":"4","author":"Mohammadi","year":"2012","journal-title":"Viruses"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2174\/157016210790416361","article-title":"Feline immunodeficiency virus model for designing HIV\/AIDS vaccines","volume":"8","author":"Yamamoto","year":"2010","journal-title":"Curr. HIV Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.vetimm.2009.10.003","article-title":"FIV Gag: Virus assembly and host-cell interactions","volume":"134","author":"Luttge","year":"2010","journal-title":"Vet. Immunol. Immunopathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1439-0442.1995.tb00392.x","article-title":"Long-Term Treatment of Diseased, FIV-Seropositive Field Cats with Azidothymidine (AZT)","volume":"42","author":"Hart","year":"1995","journal-title":"J. Vet. Med. Ser. A"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1093\/jac\/34.4.589","article-title":"Susceptibility in Cell Culture of Feline Immunodeficiency Virus to Eighteen Antiviral Agents","volume":"34","author":"Smyth","year":"1994","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Hosie, M., Techakriengkrai, N., B\u0119czkowski, P., Harris, M., Logan, N., and Willett, B. (2017). The Comparative Value of Feline Virology Research: Can Findings from the Feline Lentiviral Vaccine Be Translated to Humans?. Vet. Sci., 4.","DOI":"10.3390\/vetsci4010007"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s007050050679","article-title":"Investigation into the mode of action of R-91650, an arylpiperazinyl fluoroquinolone, on feline immunodeficiency virus replication inhibitory activity","volume":"145","author":"Kashiwase","year":"2000","journal-title":"Arch. Virol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"27403","DOI":"10.1038\/srep27403","article-title":"Identification of potent maturation inhibitors against HIV-1 clade C","volume":"6","author":"Timilsina","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(13)70692-3","article-title":"Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: Results from the phase 3 HPTN 052 randomised controlled trial","volume":"14","author":"Grinsztejn","year":"2014","journal-title":"Lancet Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/00042560-199506000-00002","article-title":"Early suppression of viremia by ZDV does not alter the spread of feline immunodeficiency virus infection in cats","volume":"9","author":"Hayes","year":"1995","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/(SICI)1097-0134(20000101)38:1<29::AID-PROT4>3.0.CO;2-N","article-title":"Structural studies of FIV and HIV-1 proteases complexed with an efficient inhibitor of FIV protease","volume":"38","author":"Li","year":"2000","journal-title":"Proteins Struct. Funct. Genet."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1128\/AAC.02560-15","article-title":"Identification and Characterization of BMS-955176, a Second-Generation HIV-1 Maturation Inhibitor with Improved Potency, Antiviral Spectrum, and Gag Polymorphic Coverage","volume":"60","author":"Protack","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"7512","DOI":"10.1016\/j.bmcl.2012.10.034","article-title":"Inhibition of HIV-1 capsid assembly: Optimization of the antiviral potency by site selective modifications at N1, C2 and C16 of a 5-(5-furan-2-yl-pyrazol-1-yl)-1H-benzimidazole scaffold","volume":"22","author":"Tremblay","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"a006924","DOI":"10.1101\/cshperspect.a006924","article-title":"HIV-1 assembly, budding, and maturation","volume":"2","author":"Sundquist","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3389\/fchem.2014.00009","article-title":"Allosteric modulation of protein oligomerization: An emerging approach to drug design","volume":"2","author":"Gabizon","year":"2014","journal-title":"Front. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e02155-16","DOI":"10.1128\/JVI.02155-16","article-title":"Inhibition of HIV-1 Maturation via Small Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein","volume":"91","author":"Wang","year":"2017","journal-title":"J. Virol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.chom.2010.02.007","article-title":"Flexible Use of Nuclear Import Pathways by HIV-1","volume":"7","author":"Lee","year":"2011","journal-title":"Cell Host Microbe"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Price, A.J., Fletcher, A.J., Schaller, T., Elliott, T., Lee, K.E., KewalRamani, V.N., Chin, J.W., Towers, G.J., and James, L.C. (2012). CPSF6 Defines a Conserved Capsid Interface that Modulates HIV-1 Replication. PLoS Pathog., 8.","DOI":"10.2210\/pdb4b4n\/pdb"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Price, A.J., Jacques, D.A., Mcewan, W.A., Fletcher, A.J., Essig, S., Chin, J.W., Halambage, U.D., Aiken, C., and James, L.C. (2014). Host Cofactors and Pharmacologic Ligands Share an Essential Interface in HIV-1 Capsid That Is Lost upon Disassembly. PLoS Pathog., 10.","DOI":"10.1371\/journal.ppat.1004459"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1128\/JVI.01406-10","article-title":"Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization","volume":"85","author":"Shi","year":"2011","journal-title":"J. Virol."},{"key":"ref_22","first-page":"270","article-title":"HIV-1 capsid inhibitors as antiretroviral agents Suzie","volume":"14","author":"Valente","year":"2017","journal-title":"Curr. HIV Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4622","DOI":"10.1128\/AAC.00985-13","article-title":"Discovery of novel small-molecule HIV-1 replication inhibitors that stabilize capsid complexes","volume":"57","author":"Lamorte","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0022-2836(03)00289-4","article-title":"Antiviral Inhibition of the HIV-1 Capsid Protein","volume":"327","author":"Tang","year":"2003","journal-title":"J. Mol. Biol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"8472","DOI":"10.1128\/JVI.05006-11","article-title":"Inhibiting Early-Stage Events in HIV-1 Replication by Small-Molecule Targeting of the HIV-1 Capsid","volume":"86","author":"Kortagere","year":"2012","journal-title":"J. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1107\/S0907444913006409","article-title":"A novel inhibitor-binding site on the HIV-1 capsid N-terminal domain leads to improved crystallization via compound-mediated dimerization research papers","volume":"69","author":"Lemke","year":"2013","journal-title":"Acta Crystallogr. Sect. D"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Rihn, S.J., Wilson, S.J., Loman, N.J., Alim, M., Bakker, S.E., Bhella, D., Gifford, R.J., Rixon, F.J., and Bieniasz, P.D. (2013). Extreme Genetic Fragility of the HIV-1 Capsid. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003461"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1002\/cmdc.201500385","article-title":"Potent and Selective Inhibitors of Trypanosoma cruzi Triosephosphate Isomerase with Concomitant Inhibition of Cruzipain: Inhibition of Parasite Growth through Multitarget Activity","volume":"11","author":"Aguilera","year":"2016","journal-title":"ChemMedChem"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3984","DOI":"10.1021\/jm500018m","article-title":"Optimization of antitrypanosomatid agents: Identification of nonmutagenic drug candidates with in vivo activity","volume":"57","author":"Varela","year":"2014","journal-title":"J. Med. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ejmech.2015.06.018","article-title":"Development of bis-thiazoles as inhibitors of triosephosphate isomerase from Trypanosoma cruzi. Identification of new non-mutagenic agents that are active in vivo","volume":"100","author":"Varela","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3401","DOI":"10.1016\/j.bmcl.2013.03.074","article-title":"Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 2: Structure-activity relationships (SAR) of the C3-phenyl moiety","volume":"23","author":"Fader","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"6643","DOI":"10.1128\/JVI.00493-12","article-title":"Distinct effects of two HIV-1 capsid assembly inhibitor families that bind the same site within the N-terminal domain of the viral CA protein","volume":"86","author":"Lemke","year":"2012","journal-title":"J. Virol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1128\/AAC.02574-15","article-title":"Ebselen, a Small-Molecule Capsid Inhibitor of HIV-1 Replication","volume":"60","author":"Brady","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1126\/science.aaa5182","article-title":"Conformational plasticity of a native retroviral capsid revealed by X-ray crystallography","volume":"349","author":"Obal","year":"2015","journal-title":"Science"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Serri\u00e8re, J., Fenel, D., Schoehn, G., Gouet, P., and Guillon, C. (2013). Biophysical characterization of the feline immunodeficiency virus p24 capsid protein conformation and in vitro capsid assembly. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0056424"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1016\/j.ejmech.2010.09.034","article-title":"Massive screening yields novel and selective Trypanosoma cruzi triosephosphate isomerase dimer-interface-irreversible inhibitors with anti-trypanosomal activity","volume":"45","author":"Alvarez","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"\u00c1lvarez, G., Perdomo, C., Coronel, C., Aguilera, E., Varela, J., Aparicio, G., Zolessi, F.R., Cabrera, N., Vega, C., and Rol\u00f3n, M. (2017). Multi-anti-parasitic activity of arylidene ketones and thiazolidene hydrazines against Trypanosoma cruzi and Leishmania spp.. Molecules, 22.","DOI":"10.3390\/molecules22050709"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nature19098","article-title":"HIV-1 uses dynamic capsid pores to import nucleotides and fuel encapsidated DNA synthesis","volume":"536","author":"Jacques","year":"2016","journal-title":"Nature"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Folio, C., Sierra, N., Dujardin, M., Alvarez, G., and Guillon, C. (2017). Crystal structure of the full-length feline immunodeficiency virus capsid protein shows an N-terminal \u03b2-hairpin in the absence of N-terminal proline. Viruses, 9.","DOI":"10.2210\/pdb5na2\/pdb"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/nar\/gku401","article-title":"ProTox: A web server for the in silico prediction of rodent oral toxicity","volume":"42","author":"Drwal","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"16816","DOI":"10.1038\/s41598-017-17071-0","article-title":"Bayesian Analysis of MicroScale Thermophoresis Data to Quantify Affinity of Protein:Protein Interactions with Human Survivin","volume":"7","author":"Jensen","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1107\/S0907444910007493","article-title":"Features and development of Coot","volume":"66","author":"Emsley","year":"2010","journal-title":"Acta Crystallogr. Sect. D Biol. Crystallogr."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Fort, R.S., Math\u00f3, C., Geraldo, M.V., Ottati, M.C., Yamashita, A.S., Saito, K.C., Leite, K.R.M., M\u00e9ndez, M., Maedo, N., and M\u00e9ndez, L. (2018). Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth. BMC Cancer, 18.","DOI":"10.1186\/s12885-018-4049-7"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/11\/3\/67\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:11:18Z","timestamp":1760195478000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/11\/3\/67"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,10]]},"references-count":45,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,9]]}},"alternative-id":["ph11030067"],"URL":"https:\/\/doi.org\/10.3390\/ph11030067","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,10]]}}}